Lupin Limited Secures FDA Approval for Oral Suspension of Sodium Zirconium Cyclosilicate#United_States#FDA_Approval#Mumbai#Lupin_Limited#Sodium_Zirconium
Lupin Limited Secures FDA Approval for Oral Suspension of Sodium Zirconium Cyclosilicate
Lupin Limited has received FDA approval for Sodium Zirconium Cyclosilicate oral suspension, expanding treatment options for hyperkalemia in the U.S.
third-news.com
August 10, 2026 at 3:51 PM
Lupin Limited Secures FDA Approval for Oral Suspension of Sodium Zirconium Cyclosilicate#United_States#FDA_Approval#Mumbai#Lupin_Limited#Sodium_Zirconium